Related Experiment Video
Updated: May 29, 2026

Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device
Published on: September 24, 2020
Remifentanil use in emergency department patients: initial experience
Alfred Sacchetti1, Jennifer Jachowski, Josephine Heisler
1Department of Emergency Medicine, Our Lady of Lourdes Medical Center, 1600 Haddon Avenue, Camden, NJ 08103, USA. sacchetti1011@gmail.com
Introduction:
This study examines the use of remifentanil, an ultra-short-acting opioid, in emergency department (ED) patients.
Methods:
Chart review of ED patients receiving remifentanil for procedural sedation in an urban general ED.
Results:
50 patients over a 28-month period with a mean age of 30.6 years (±2.6) were reviewed. Procedures performed included: abscess drainage (13); fracture care (9); thoracostomy (8); lumbar puncture (7); shoulder reduction (3); cardioversion (3) and others (7). Six (12%) cases received additional rescue medications. All procedures were successfully completed in the ED. No complications were recorded but 21 (42%) were admitted for underlying pathology.
Conclusion:
Remifentanil is a safe and effective medication for ED use.
Related Concept Videos
Parenteral Anesthetics: Overview
Inhalational Anesthetics: Overview
Local Anesthetics: Clinical Application as Epidural Anesthesia
Since epidural anesthetics can be infused through an epidural catheter, all types of drugs, including short-acting ones, can be administered. Chloroprocaine and lidocaine are examples of short and long-duration anesthetics, respectively. Bupivacaine...
Cardiopulmonary Resuscitation IV: Pharmacological Management
Drug Delivery: Enteral Route
Drugs in...
Opioid Analgesics: Synthetic and Semisynthetic Opioids
